Alecensa 150mg Capsules (224) – Alectinib Hydrochloride ALK+ Lung Cancer Therapy
Alecensa 150mg capsules contain alectinib hydrochloride, a targeted therapy for ALK-positive non-small cell lung cancer, designed to inhibit cancer growth and improve long-term outcomes.
- The description claims strong efficacy and central nervous system penetration.
- The description claims it is clinically proven.
Variants (1)
- Default Title — 11744.40 JOD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
80%